Aprea Therapeutics' Promising Cancer Drug Candidate Warrants Buy Rating
TipRanksApr 12 23:35
Optimistic Outlook for Aprea Therapeutics' Oncology Pipeline: A Comprehensive Buy Rating Analysis
TipRanksApr 11 18:26
Aprea Therapeutics: Strong Financials and Promising Clinical Pipeline Support Buy Rating
TipRanksMar 28 04:05
Analysts Offer Insights on Healthcare Companies: Aprea Therapeutics (APRE), Biogen (BIIB) and Mesoblast Limited (OtherMEOBF)
TipRanksMar 27 20:20
Buy Rating Affirmed: Aprea Therapeutics Poised for Growth With Strong Pipeline Momentum Into 2024
TipRanksMar 26 23:15
Aprea Therapeutics: Strong Buy Rating on Robust Financials and Promising Drug Pipeline
TipRanksMar 20 03:05
Buy Rating Affirmed for Aprea Therapeutics Amid Strong Clinical Results and Strategic Advantages
TipRanksJan 12 01:35
Aprea Therapeutics Bags a 'Buy' Rating: Promising Clinical Developments and Strong Financial Position Highlighted
TipRanksNov 11, 2023 20:05
Positive Financial Health and Promising Clinical Trials Propel Aprea Therapeutics to a Buy Rating: An Analysis by H.C. Wainwright
TipRanksNov 10, 2023 19:57
HC Wainwright & Co. Reiterates Buy on Aprea Therapeutics, Maintains $20 Price Target
BenzingaNov 1, 2023 18:59
Aprea Therapeutics Analyst Ratings
BenzingaNov 1, 2023 18:56
Aprea Therapeutics' Promising Clinical Data and Distinctive Drug Profile: An Analysis of Jason McCarthy's Buy Rating
TipRanksOct 19, 2023 01:05
Positive Outlook for Aprea Therapeutics: Promising Developments and Safety Profile of ATRN-119 Bolster Buy Rating
TipRanksOct 16, 2023 23:06
Aprea Therapeutics (APRE) Gets a Buy From Maxim Group
TipRanksSep 21, 2023 19:47
HC Wainwright & Co. Reiterates Buy on Aprea Therapeutics, Maintains $20 Price Target
BenzingaSep 13, 2023 18:30
Aprea Therapeutics Analyst Ratings
BenzingaSep 13, 2023 18:29
Maxim Group Sticks to Their Buy Rating for Aprea Therapeutics (APRE)
TipRanksAug 11, 2023 21:45
HC Wainwright & Co. Reiterates Buy on Aprea Therapeutics, Maintains $20 Price Target
BenzingaAug 11, 2023 00:03
Analysts Are Bullish on These Healthcare Stocks: Citius Pharmaceuticals (CTXR), Aprea Therapeutics (APRE)
TipRanksAug 10, 2023 22:30
Aprea Therapeutics (APRE) Receives a Buy From H.C. Wainwright
TipRanksMay 16, 2023 18:25
No Data
No Data